NorthWest Biotherapeutics Inc (NWBO)

[Galzus Research]

I appreciate you amplifying my article, ROS-CH. I understand that NWBO has one of the most active retail shareholder bases in all of biotech. So I thought I'd jump in here in case any of you guys have questions about the article but don't have access to Seeking Alpha.

Because I have a limited number of posts, I'd like to go ahead and respond to a few things on this reply chain I'm seeing so far:

1) While I am writing for Seeking Alpha as a side gig, I have no affiliation/employment with Seeking Alpha. I work in the oncology world, though.

2) I, personally, own the Galzus Research pseudonym. There was a time where I wrote with my real name, but I elected to stop doing that after there were issues related to doxxing and contacting my employer. I would rather be able to say what I want without fear of outsized repercussions. It only takes one crazy to cause a lot of trouble.

3) I agree that on the whole Seeking Alpha has a lot of unsophisticated writers, and I would count myself among them, at least on the financial side of things. The fact that we're asked to make "calls" is emblematic of this, as someone pointed out my 30% "win" rate. In biotech, too much happens that is completely unpredictable to bother with trying to predict, which is why I talk about the buy/sell not as recommendations, but where my sentiment falls on the risk/benefit continuum. "Sell" here, as I stated in my article, would be more along the lines of "I would strongly recommend my brother not leverage himself to invest in this one" as opposed to "OMFG please sell all your holdings in this!"

But I thank you all for reading, again, and hope there was something to gain. I understand the subject of criticism is a sore topic with the ongoing lawsuit. I do not feel like NWBO is a sure loss, but there are a lot of concerning factors related to this potential approval that I would definitely be cautious about.